Zhongchao (NASDAQ:ZCMD – Get Free Report) and 111 (NASDAQ:YI – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.
Risk & Volatility
Zhongchao has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. Comparatively, 111 has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500.
Insider & Institutional Ownership
1.7% of Zhongchao shares are held by institutional investors. Comparatively, 21.3% of 111 shares are held by institutional investors. 28.6% of Zhongchao shares are held by company insiders. Comparatively, 43.9% of 111 shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Zhongchao | N/A | N/A | N/A |
| 111 | -0.76% | N/A | -3.80% |
Earnings and Valuation
This table compares Zhongchao and 111″s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Zhongchao | $11.38 million | 0.17 | -$6.31 million | N/A | N/A |
| 111 | $1.80 billion | 0.02 | -$9.65 million | ($1.40) | -2.66 |
Zhongchao has higher earnings, but lower revenue than 111.
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Zhongchao and 111, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Zhongchao | 1 | 0 | 0 | 0 | 1.00 |
| 111 | 1 | 0 | 0 | 0 | 1.00 |
About Zhongchao
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.
About 111
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
Receive News & Ratings for Zhongchao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhongchao and related companies with MarketBeat.com's FREE daily email newsletter.
